Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal Yellow agouti mutation - Usefulness of leptin for thetreatment of obesity-associated diabetes

Leptin acts as an adipocyte-derived blood-borne satiety factor that can inc rease glucose metabolism. To elucidate the therapeutic implications of lept in for obesity-associated diabetes, we crossed transgenic skinny mice overe xpressing leptin (Tg/+), which we have developed recently, and lethal yello w KKA(y) mice (A(y)/+), a genetic model for obesity-diabetes syndrome, and examined the metabolic phenotypes of F-1 animals. At 6 weeks of age, plasma leptin concentrations in Tg/+ mice with the A(y) allele (Tg/+:A(y)/+) were significantly higher than those in A(y)/+ mice. Although no significant di fferences in body weight were noted among Tg/+:A(y)/+ mice, A(y)/+ mice, an d their wild-type lean littermates (+/+), glucose and insulin tolerance tes ts revealed increased glucose tolerance and insulin sensitivity in Tg/+:A(y )/+ compared with A(y)/+ mice. However, at 12 weeks of age, when plasma lep tin concentrations in A(y)/+ mice were comparable to those in Tg/+:A(y)/+ m ice, Tg/+:A(y)/+ mice developed obesity-diabetes syndrome similar to that o f A(y)/+ mice. Body weights of la-week-old Tg/+:A(y)/+ and A(y)/+ mice were reduced to those of +/+ mice by a 3-week food restriction; when plasma lep tin concentrations remained high in Tg/+:A(y)/+ mice but were markedly redu ced in A(y)/+ and +/+ mice, glucose tolerance and insulin sensitivity in Tg /+:A(y)/+ mice were markedly improved as compared with A(y)/+ and +/+ mice. The present study demonstrates that hyperleptinemia can delay the onset of impaired glucose metabolism and accelerate the recovery from diabetes duri ng caloric restriction in Tg/+:A(y)/+ mice, thereby suggesting the potentia l usefulness of leptin in combination with a long-term caloric restriction for the treatment of obesity-associated diabetes.